) The Cancer Control Research Program remains focused on the reduction of the burden of cancer on individuals and society.
The specific aims are the application of multidisciplinary research to: (1) Identify markers that predict increased cancer susceptibility, (2) Evaluate promising interventions for the prevention of cancer, (3) Develop and test new early detection strategies and (4) Evaluate interventions to improve the quality of life for cancer patients and their care-givers. Research in cancer susceptibility/carcinogenesis has received expanded funding along with the recruitment of high-risk cohorts that are followed longitudinally. Prevention studies are underway in breast, lung and prostate cancer. Imaging research has progressed and focused on translational efforts providing evaluation of important CAD methods in clinical practice. Behavioral research funded studies address the entire spectrum of cancer control research from assessing the determinants of risk perception to quality of life and health outcomes. The infrastructure has expanded to include the DOD-funded Advanced Cancer Detection Center and the Center for Mathematical Modeling of Image Data Across the Sciences. Both new centers provide a focus for Cancer Control research and support pilot studies that have led to peer-reviewed funding. In addition, Lifetime Cancer Screening has grown to serve more than 17,000 patient encounters annually and houses multiple cancer control research projects. Program growth has been remarkable with an increase in annual funding from $3.8 to $8.8 million in only two years. Collaborations with basic science and clinical investigations have expanded rapidly through targeted recruitment, investment of institutional resources and recently awarded collaborative grants. This has resulted in laboratory scientists, clinical investigators, nurses and health services researchers jointly addressing the spectrum of research from basic science to pre-clinical to clinical translation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA076292-04
Application #
6430480
Study Section
Project Start
1998-02-19
Project End
2006-01-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2001
Total Cost
$305,280
Indirect Cost
Name
University of South Florida
Department
Type
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Akuffo, Afua A; Alontaga, Aileen Y; Metcalf, Rainer et al. (2018) Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon. J Biol Chem 293:6187-6200
Mahajan, Nupam P; Coppola, Domenico; Kim, Jongphil et al. (2018) Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells. Sci Rep 8:1954
Gonzalez, Brian D; Hoogland, Aasha I; Kasting, Monica L et al. (2018) Psychosocial impact of BRCA testing in young Black breast cancer survivors. Psychooncology 27:2778-2785
Christy, Shannon M; Schmidt, Alyssa; Wang, Hsiao-Lan et al. (2018) Understanding Cancer Worry Among Patients in a Community Clinic-Based Colorectal Cancer Screening Intervention Study. Nurs Res 67:275-285
Chang, James M; Kosiorek, Heidi E; Dueck, Amylou C et al. (2018) Stratifying SLN incidence in intermediate thickness melanoma patients. Am J Surg 215:699-706
Rounbehler, Robert J; Berglund, Anders E; Gerke, Travis et al. (2018) Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer. Cancer Epidemiol Biomarkers Prev 27:1376-1383
Sun, X; Ren, Y; Gunawan, S et al. (2018) Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. Leukemia 32:1246-1249
Porubsky, Caitlin; Teer, Jamie K; Zhang, Yonghong et al. (2018) Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus. J Cutan Pathol 45:180-183
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
Li, Yafang; Xiao, Xiangjun; Han, Younghun et al. (2018) Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis 39:336-346

Showing the most recent 10 out of 1254 publications